Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simulations PlusSLP 86 Earnings Yield (Joel Greenblatt) % is 3.89% as of May. 2026, which is 127% above its 10-year median of 1.71. GuruFocus rates SLP with a GF Scoreâ„¢ of 86/100 and a GF Valueâ„¢ of $35.56 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Simulations Plus ranks better than 51.31% on this metric.
Simulations Plus's Enterprise Value for the quarter that ended in May. 2026 was $295.89 Mil.
Simulations Plus's EBIT for the trailing twelve months (TTM) ended in May. 2026 was $11.50 Mil. Simulations Plus's Earnings Yield (Joel Greenblatt) for the quarter that ended in May. 2026 was 3.89%.
The historical rank and industry rank for Simulations Plus's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
SLP'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.51 Med: 1.71 Max: 5.3
Current: 3.6
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Simulations Plus was 5.30%. The lowest was 0.51%. And the median was 1.71%.
SLP's Earnings Yield (Joel Greenblatt) % is ranked better than 51.31% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 3.24
vs SLP: 3.60
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Simulations Plus's Forward Rate of Return (Yacktman) % for the quarter that ended in May. 2026 was 2.01%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Simulations Plus (NAS:SLP) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Simulations Plus Earnings Yield (Joel Greenblatt) % Related Terms
Simulations Plus Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Simulations Plus's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simulations Plus Earnings Yield (Joel Greenblatt) % Chart
For the Health Information Services subindustry, Simulations Plus's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simulations Plus Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Simulations Plus's Earnings Yield (Joel Greenblatt) % falls into.
Simulations Plus Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Simulations Pluss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Aug. 2025 is calculated as
Simulations Plus's EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.50 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 3.89% mean?
Simulations Plus (SLP) has a Earnings Yield (Joel Greenblatt) % of 3.89% as of May. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Simulations Plus and its competitors. This is 127% above median its historical median of 1.71. Over the past decade, Simulations Plus' Earnings Yield (Joel Greenblatt) % has ranged from 0.51 to 5.30. According to the industry distribution chart, Simulations Plus ranks #334 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 48.7%.
Is Simulations Plus' Earnings Yield (Joel Greenblatt) % too high?
Simulations Plus' current Earnings Yield (Joel Greenblatt) % of 3.89% is 127% above median its 10-year median of 1.71. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 5.30. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.24. Simulations Plus' value of 3.89% is 20.1% above this industry median. Based on the distribution chart, Simulations Plus ranks #334 out of 686 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Simulations Plus has a GF Scoreâ„¢ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Earnings Yield (Joel Greenblatt) % compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #334 out of 686 companies for Earnings Yield (Joel Greenblatt) %. This puts Simulations Plus in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.24. Simulations Plus' value of 3.89% is 20.1% above this benchmark. Historically, Simulations Plus' own Earnings Yield (Joel Greenblatt) % has ranged from 0.51 to 5.30 over the past decade. While the company's 10-year median is 1.71 vs. the industry median of 3.24, Simulations Plus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.24, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current Earnings Yield (Joel Greenblatt) % of 3.89% is 20.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current Earnings Yield (Joel Greenblatt) % is 3.89%, which is 127% above median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $35.56, compared to a current price of $18.23 — trading 48.7% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 3.89%, which is 127% above median its 10-year median of 1.71 and 20.1% above the Healthcare Providers & Services industry median of 3.24. Simulations Plus' overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Simulations Plus (SLP), the current Earnings Yield (Joel Greenblatt) % is 3.89% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (SLP) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of $18.23 is trading 48.7% below its estimated GF Value™ of $35.56.
GuruFocus considers Simulations Plus to be Significantly Undervalued.
Key valuation signals for SLP:
Earnings Yield (Joel Greenblatt) %: 3.89% (127% above median its 10-year median of 1.71)
GF Value™: $35.56 vs. price of $18.23 (48.7% below fair value)
Industry Position: 20.1% above the Healthcare Providers & Services median (#334 of 686)
No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
86GF Score
Get the complete analysis for SLP
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SLP has been successfully added to your 
